Summary
External quality assurance (EQA) schemes are essential for improvement of accuracy, reliability and comparability of results of biochemical genetic tests. ERNDIM (European Research Network for evaluation and improvement of screening, Diagnosis and treatment of Inherited disorders of Metabolism), established in 1994, operates nine EQA schemes for biochemical genetic testing according to international norms and recommendations. These comprise qualitative schemes for amino acids, organic acids, purines and pyrimidines, special assays in serum and urine and white cell cystine, qualitative organic acid and acylcarnitine schemes, as well as diagnostic proficiency testing. The total number of participants has increased from 123 in 1994 to 268 in 2007. Additional activities include participation in the Eurogentest project, a laboratory directory, training, education and development of guidelines. Results from the quantitative amino acid scheme with 170 participants reveal good variation within and between laboratories of below 10% for 10 amino acids; good within-laboratory variation but intermediate inter-laboratory variation of 10–22% for 11 amino acids; and higher variation within and between laboratories for 8 amino acids. Results on samples from 51 inherited metabolic disorders from two of five centres organizing diagnostic proficiency testing indicate overall diagnostic efficiency above 80% and improved performance of individual laboratories. Comparison of results for 10 and 12 compounds in the serum and urine special assay schemes respectively for 2000 and 2007 reveal clear improvement of precision within laboratories and in inter-laboratory variation. There is considerable evidence that performance in biochemical genetic testing has improved since the introduction of ERNDIM schemes.
Similar content being viewed by others
References
Blau N, Duran M, Gibson KM, eds (2008) Laboratory Guide to the Methods in Biochemical Genetics. Berlin, Heidelberg: Springer-Verlag.
Bonham JR (2003) Diagnostic proficiency testing in the UK and Scandinavia. J Inherit Metab Dis 26(Supplement 2): 134.
Fowler B on behalf of ERNDIM (2003a) Amino acid measurement in inherited metabolic disorders (IEM): lessons from ERNDIM for treatment monitoring and long-term multicentre studies. J Inherit Metab Dis 26(supplement 2): 135.
Fowler B on behalf of ERNDIM (2003b) Quality assurance in laboratory measurements for inherited metabolic disorders (IEM): ERNDIM schemes. J Inherit Metab Dis 26(supplement 2): 135.
Peters V, Garbade SF, Langhans GF, Pollitt RJ, Downing M, Bonham J (2008) Qualitative urinary organic acid analysis: methodological approaches and performance. J Inherit Metab Dis. doi:10.1007/s10545-008-0986-7.
Rattenbury JM, Townsend JC (1990) Establishment of an external quality-assessment scheme for amino acid analyses: results from assays of samples distributed during two years. Clin Chem 36: 217–224.
Sciacovelli L, Secchiero S, Zardo L, Plebani M (2001) External quality assessment schemes: need for recognised requirements. Clin Chim Acta 309: 183–199. doi:10.1016/S0009-8981(01)00521-6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Marinus Duran
Competing interests: None declared
An erratum to this article is available at http://dx.doi.org/10.1007/s10545-008-9968-z.
Electronic Supplementary Material
Below is the link to the electronic supplementary material
Supplementary Table S1
Samples and performance achieved in the Lyon and Prague diagnostic proficiency testing schemes (DOC 167 kb)
Rights and permissions
About this article
Cite this article
Fowler, B., Burlina, A., Kozich, V. et al. Quality of analytical performance in inherited metabolic disorders: the role of ERNDIM. J Inherit Metab Dis 31, 680–689 (2008). https://doi.org/10.1007/s10545-008-1025-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-1025-4